Evidence map›Paper›PMID 42613093›Full record

ArticleBMJ global health2026

How has mental health impacted the HIV epidemic and how has the HIV epidemic impacted mental health in Western Kenya? A mathematical modelling study.

Daniel Citron, Hae-Young Kim, Roscoe Kasujja, Samuel Mwalili, Duncan Gathungu, Chikumbi Chambwe, Ingrida Platais, Frey B Assefa, R Scott Braithwaite, Anna Bershteyn

Abstract read
In one paragraph

Article in BMJ global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniel CitronDepartment of Population Health, New York University Grossman School of Medicine, New York, New York, USA.ORCID 0000-0002-1282-4176
Hae-Young KimDepartment of Population Health, New York University Grossman School of Medicine, New York, New York, USA.ORCID 0000-0002-5124-1555
Roscoe KasujjaStrongMinds, Kampala, Uganda.
Samuel MwaliliInstitute of Mathematical Sciences, Strathmore University, Nairobi, Kenya.
Duncan GathunguInstitute of Mathematical Sciences, Strathmore University, Nairobi, Kenya.
Chikumbi ChambweCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Ingrida PlataisDepartment of Population Health, New York University Grossman School of Medicine, New York, New York, USA.
Frey B AssefaDepartment of Population Health, New York University Grossman School of Medicine, New York, New York, USA.
R Scott BraithwaiteDepartment of Population Health, New York University Grossman School of Medicine, New York, New York, USA.
Anna BershteynDepartment of Population Health, New York University Grossman School of Medicine, New York, New York, USA bershteyn@alum.mit.edu.ORCID 0000-0002-6604-7093

Funding

Can mental health services break the cycle perpetuating HIV hotspots in sub-Saharan Africa?R01MH124478 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BERSHTEYN, ANNA · 2021 to 2025
$3.2M
NIMH NIH HHS R01 MH124478
6 · The paper itself

Abstract

backgroundIn eastern and southern Africa, HIV and depression lead to substantial morbidity and mortality. Each condition affects the other: people living with HIV (PLHIV) have higher depression rates, while depression increases HIV acquisition and hinders treatment. The combined impact of HIV-depression interactions on HIV and mental health remains poorly understood.

methodsWe adapted the EMOD-HIV simulation model to incorporate depression incidence, recovery and relapse. We modelled a bidirectional scenario between HIV and depression: HIV increased depression incidence; depression increased HIV incidence and reduced HIV care outcomes. In a counterfactual scenario, all HIV-depression interactions were removed. We estimated how interactions impacted depression episodes, HIV acquisitions, HIV-related deaths and HIV treatment benefits in a high-prevalence region of Western Kenya, 1985-2035.

resultsWithout interactions, the model projected 1.23 million (95% CI 1.21M to 1.24M) HIV acquisitions, 658 000 (95% CI 650 000 to 666 000) HIV deaths and 12.88 million (95% CI 12.87M to 12.89M) depression episodes. HIV-depression interactions increased depression episodes by 9.76% (95% CI 9.67% to 9.87%), HIV acquisitions by 12.3% (95% CI 12.0% to 12.6%) and HIV deaths by 12.5% (95% CI 12.2% to 12.9%). These interactions also diminished HIV treatment benefits, with 7.72% (95% CI 7.39% to 8.07%) fewer HIV acquisitions and 3.88% (95% CI 3.71% to 4.05%) fewer deaths averted per person-year on treatment. In secondary analyses, increased depression incidence among PLHIV had the greatest effect on HIV outcomes, contributing 7.26% of acquisitions and 7.55% of deaths.

conclusionHIV-depression interactions have worsened both epidemics. Depression's effects on HIV incidence have been especially deleterious, while its effect on HIV care engagement is increasingly important.

Indexed as

DepressionEpidemicsHIV InfectionsMental HealthAdultFemaleHumansIncidenceKenyaMaleModels, TheoreticalPrevalenceGlobal HealthHIVKenyaMathematical modellingMental Health & Psychiatry

Identifiers

PMID42613093
PMCPMC13504884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.